Previous month Previous day Next day Next month
By Year By Month By Week Today Search Jump to month
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Nanotechnology Research Platforms (U01)


Thursday, December 31, 2015


The National Cancer Institute (NCI) supports the development of translational nanotechnologies with applications in the diagnosis and therapy of cancer through its Alliance for Nanotechnology in Cancer program. Cancer nanotechnology is widely viewed as a promising and highly innovative field, with the potential for transformative scientific advancements and practical applications relevant to cancer.

The forthcoming Funding Opportunity Announcement (FOA) introduced by this Notice, to be issued by the NCI, will solicit U01 (Research Project-Cooperative Agreements) applications. This initiative is open to all qualified applicants regardless of whether or not they participated in the previous cycle of the Alliance for Nanotechnology in Cancer program.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications.    

This FOA will utilize the U01 activity code. Details of the planned FOA are provided below.

The forthcoming FOA announced by this Notice will be open to all qualified applicants with the appropriate expertise to establish, evolve, and maintain a cancer nanotechnology research program.

The proposed research projects are expected to address major questions in cancer biology and cancer interventions through the use of innovative nanotechnology. These projects will be expected to develop further understanding of nanomaterial interactions with biological systems and mechanisms of their in vivo delivery. To advance such new nanotechnology discoveries, the proposed platform projects should take advantage of the collaborative environment of the Alliance network.  

Further details will be included in the forthcoming FOA.

For more information, please visit: